Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11573032 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| SCHEMBL21268022 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| SCHEMBL9397943 | 0.77 | ESR1 (0.46) | ALDH1A1TDP1CYP3A4ALOX15MAOB | |
| SCHEMBL1681787 | 0.77 | AKR1C3 (0.47) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| Styrene SCHEMBL23291090 | 0.75 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| SCHEMBL489257 | 0.75 | GLA (0.61) | ALDH1A1TSHRGLATDP1CYP3A4 | |
| Styrene SCHEMBL5914572 | 0.75 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| SCHEMBL11185426 | 0.75 | GLA (0.61) | ALDH1A1TSHRGLATDP1CYP3A4 | |
| Styrene SCHEMBL530074 | 0.75 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3GLATDP1 | |
| Styrene SCHEMBL1408424 | 0.75 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3GLATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3137529-B1 | PROCESS FOR MAKING A POLYMER POLYOL | BASF SE (DE) | 2020-06-17 | — | — | EP | claimed |
| US-10370479-B2 | Process for making a polymer polyol | BASF SE (DE) | 2019-08-06 | — | — | US | claimed |
| EP-3137529-A1 | PROCESS FOR MAKING A POLYMER POLYOL | BASF SE (DE) | 2017-03-08 | — | — | EP | claimed |
| US-20170044297-A1 | PROCESS FOR MAKING A POLYMER POLYOL | BASF SE (DE) | 2017-02-16 | — | — | US | claimed |
| WO-2015165761-A1 | PROCESS FOR MAKING A POLYMER POLYOL | BASF SE (DE) | 2015-11-05 | — | — | WO | claimed |
| EP-2786985-A2 | Antagonists of the glucagon receptor | Metabasis Therapeutics, Inc. (US) | 2014-10-08 | — | — | EP | claimed |
| EP-2129654-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | Metabasis Therapeutics, Inc. (US) | 2009-12-09 | — | — | EP | claimed |
| WO-2008098244-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | METABASIS THERAPEUTICS, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| EP-1506240-A1 | GRAFT POLYOLS PREPARED BY A CONTINUOUS PROCESS | BASF CORPORATION (US) | 2005-02-16 | — | — | EP | claimed |
| WO-2003097710-A1 | GRAFT POLYOLS PREPARED BY A CONTINUOUS PROCESS | BASF CORPORATION (US) | 2003-11-27 | — | — | WO | claimed |
| US-6090902-A | Organopolysiloxane-modified graft copolymers | DOW CORNING CORPORATION (US) | 2000-07-18 | — | — | US | claimed |
| EP-1013681-A1 | Organopolysiloxane-modified graft copolymers | DOW CORNING CORPORATION (US) | 2000-06-28 | — | — | EP | claimed |
| EP-0185872-B1 | 1-PHENYL-2-METHYL-3-HYDROXY-(3-ACYLOXY)-ALKYL COMPOUNDS AND THEIR USE AS PERFUMES | BASF Aktiengesellschaft (DE) | 1990-02-07 | — | — | EP | claimed |
| JP-2000562-A | — | — | None | — | — | JP | disclosed |
| US-12017980-B2 | Monofunctional phenolic compound, active ester resin and method for producing the same, and thermosetting resin composition and cured product thereof | DIC CORPORATION (JP) | 2024-06-25 | — | — | US | disclosed |
| CN-118185233-A | Resin composition | 味之素株式会社 | 2024-06-14 | — | — | CN | disclosed |
| EP-0323082-A2 | Catalysts | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-07-05 | — | — | EP | disclosed |
| EP-0250090-A2 | Storage stable latently curable acrylic formulations employing polymeric hydroperoxides | LOCTITE CORPORATION (US) | 1987-12-23 | — | — | EP | disclosed |
| EP-0185872-A1 | 1-Phenyl-2-methyl-3-hydroxy-(3-acyloxy)-alkyl compounds and their use as perfumes | BASF Aktiengesellschaft (DE) | 1986-07-02 | — | — | EP | disclosed |
| US-4020005-A | Gelled reagent materials | LANG JOHN L | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12017980-B2 | Monofunctional phenolic compound, active ester resin and method for producing the same, and thermosetting resin composition and cured product thereof | JMJD7, KDM7A, KDM4A | ALDH1A1 474/4885TSHR 4809/4885AKR1C3 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.